Comparison

ELISA Kit for Brain Natriuretic Peptide (BNP)

Item no. CEA541Hu-10x96T
Manufacturer Cloud-Clone
Amount 10x96 T
Quantity options 10x96 T 24 T 48 T 5x96 T 96 T
Category
Type Elisa-Kit
Specific against Human (Homo sapiens)
Sensitivity The minimum detectable dose of this kit is typically less than 9.67pg/mL
Citations B-type natriuretic peptide, vascular endothelial growth factor, endothelin-1, and nitric oxide synthase in chronic mountain sickness
ELEVATED ST2 SERUM LEVELS A BIOMARKER FOR CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY
Why does Adenotonsillectomy Not Correct Enuresis in All Children with Sleep Disordered Breathing?
Improvement in the prediction of exercise-induced elevation of left ventricular filling pressure in patients with normal left ventricular ejection fraction.
Plasma concentration of fibronectin is decreased in patients with hypertrophic cardiomyopathy
High-intensity interval training enhances mitochondrial bioenergetics of platelets in patients with heart failure
Determinants of Increased Aortic Diameters in Young Normotensive Patients With Turner Syndrome Without Structural Heart Disease
Signature-oriented investigation of the efficacy of multicomponent drugs against heart failure
Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes
Dapagliflozin: a Sodium-glucose Cotransporter 2 Inhibitor, Attenuates Angiotensin II-induced Cardiac Fibrotic Remodeling by Regulating TGF¦Â1/Smad ¡­
ECLASS 10.1 32160605
ECLASS 11.0 32160605
UNSPSC 41116126
Alias GC-B,B-Type Natriuretic Peptide,Ventricular Natriuretic Peptide,Gamma-brain natriuretic peptide,Brain natriuretic peptide 32
Available
Specificity Homo sapiens (Human)
Manufacturer - Applications
Enzyme-linked immunosorbent assay for Antigen Detection.
Manufacturer - Category
ELISA CLIA Kits
Sample type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Assay length
2h
Method
Competitive Inhibition
Specificity

This assay has high sensitivity and excellent specificity for detection of Brain Natriuretic Peptide (BNP).

No significant cross-reactivity or interference between Brain Natriuretic Peptide (BNP) and analogues was observed.

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Brain Natriuretic Peptide (BNP) were tested 20 times on one plate, respectively.

Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Brain Natriuretic Peptide (BNP) were tested on 3 different plates, 8 replicates in each plate.

CV(%) = SD/meanX100

Intra-Assay: CV<10%

Inter-Assay: CV<12%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.

To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Assay procedure summary
1. Prepare all reagents, samples and standards;

2. Add 50uL standard or sample to each well.

        And then add 50uL prepared Detection Reagent A immediately.

        Shake and mix. Incubate 1 hour at 37° C;

3. Aspirate and wash 3 times;

4. Add 100uL prepared Detection Reagent B. Incubate 30 minutes at 37° C;

5. Aspirate and wash 5 times;

6. Add 90uL Substrate Solution. Incubate 10-20 minutes at 37° C;

7. Add 50uL Stop Solution. Read at 450 nm immediately.
Test principle
This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to Brain Natriuretic Peptide (BNP) has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled Brain Natriuretic Peptide (BNP) and unlabeled Brain Natriuretic Peptide (BNP) (Standards or samples) with the pre-coated antibody specific to Brain Natriuretic Peptide (BNP). After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Brain Natriuretic Peptide (BNP) in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of Brain Natriuretic Peptide (BNP) in the sample.
Manufacturer - Research Area
Cardiovascular biology; Neuro science; Hormone metabolism;

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10x96 T
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close